Clinical trial
Combination Chemotherapy in Treating Patients With Colon Cancer
NCT00046995 · Groupe Regional d'Etudes du Cancer Colorectal, Other · Unknown status
Key facts
| NCT number | NCT00046995 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Colon Cancer |
| Official title | 5-Fluorouracil-Leucovorin With or Without Carboplatin as Adjuvant Treatment for Primary Dukes B2-C Colon Cancer; Chronomodulated Versus Standard Administration. A Multicenter Randomized Phase III Trial of the GRECCR-Belgium (Study 03). |
| Lead sponsor | Groupe Regional d'Etudes du Cancer Colorectal, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, fluorouracil, leucovorin calcium, adjuvant therapy |
| Enrollment | 800 |
| Start date | May 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: